MESOBLAST LTD — All Filings
562 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
12G3-2B
20-F
3
424B3
424B4
6-K
8-A12B
ARS
CERTNAS
CORRESP
CT ORDER
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
F-3/A
F-3ASR
F-6
F-6 POS
F-6EF
POS AM
S-8
S-8 POS
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SUPPL
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 6-K | MESO-Q3FY17-31MAR2017 | 0001564590-17-011648 | May 25, 2017 | Mar 31, 2017 |
| 6-K | 6-K | 0001564590-17-008952 | May 5, 2017 | — |
| 6-K | 6-K | 0001564590-17-008203 | May 3, 2017 | — |
| 6-K | 6-K | 0001564590-17-006470 | Apr 13, 2017 | — |
| 6-K | 6-K | 0001564590-17-006206 | Apr 7, 2017 | Apr 4, 2017 |
| 6-K | 6-K | 0001564590-17-005874 | Apr 3, 2017 | — |
| 6-K | 6-K | 0001564590-17-005707 | Mar 31, 2017 | — |
| 6-K | 6-K | 0001564590-17-004754 | Mar 20, 2017 | Mar 15, 2017 |
| 6-K | 6-K | 0001564590-17-003625 | Mar 8, 2017 | — |
| 6-K | MESO-Q2FY17-31DEC2016 | 0001564590-17-002689 | Feb 28, 2017 | Dec 31, 2016 |
| 6-K | 6-K | 0001564590-17-001727 | Feb 17, 2017 | — |
| SC 13G | SC 13G | 0001193125-17-042551 | Feb 14, 2017 | — |
| SC 13G/A | MESOBLAST LIMITED | 0001193125-17-042492 | Feb 14, 2017 | — |
| SC 13G/A | SC 13G/A | 0001422848-17-000095 | Feb 13, 2017 | — |
| 6-K | 6-K APPENDIX 4C | 0001564590-17-000917 | Feb 3, 2017 | — |
| 6-K | 6-K JPM PRESENTATION | 0001564590-17-000348 | Jan 17, 2017 | Jan 13, 2017 |
| 6-K | 6-K - JP MORGAN PRESENTATION | 0001564590-17-000302 | Jan 12, 2017 | Jan 11, 2017 |
| 6-K | 6-K MALLINCKRODT SHARE ISSUE | 0001564590-17-000300 | Jan 12, 2017 | Jan 11, 2017 |
| 6-K | 6-K MALLINCKRODT | 0001564590-16-030459 | Dec 23, 2016 | — |
| 6-K | 6-K-US LEGISLATION ASX ANNOUNCEMENT | 0001564590-16-030146 | Dec 13, 2016 | — |
| 6-K | 6-K | 0001564590-16-029955 | Dec 8, 2016 | — |
| 6-K | 6-K | 0001564590-16-029319 | Nov 15, 2016 | — |
| 6-K | MESO-Q1FY17-30SEP2016 | 0001564590-16-029281 | Nov 14, 2016 | Sep 30, 2016 |
| 6-K | 6-K APPENDIX 4C | 0001564590-16-027144 | Nov 3, 2016 | — |
| 6-K | 6-K | 0001564590-16-026140 | Oct 26, 2016 | — |
| 6-K | 6-K | 0001564590-16-025874 | Oct 19, 2016 | — |
| 6-K | 6-K AJBC ANNOUNCEMENT | 0001564590-16-025786 | Oct 13, 2016 | — |
| 6-K | 6-K DIABETIC KIDNEY DISEASE PHASE II TRIAL RESULTS | 0001564590-16-025737 | Oct 11, 2016 | — |
| 6-K | 6-K | 0001564590-16-024848 | Sep 1, 2016 | — |
| 6-K | 6-K | 0001193125-16-692159 | Aug 26, 2016 | — |
| 20-F | 20-F | 0001564590-16-024688 | Aug 25, 2016 | Jun 30, 2016 |
| 6-K | 6-K RHEUMATIC CONDITIONS PRESS RELEASE | 0001564590-16-024513 | Aug 18, 2016 | — |
| 6-K | 6-K | 0001564590-16-023804 | Aug 10, 2016 | — |
| 6-K | FORM 6-K INCORPORATING APPENDIX 4C - QUARTERLY REPORT FOR THE QUARTER ENDED JUNE | 0001564590-16-021961 | Aug 2, 2016 | — |
| 6-K | FORM 6-K | 0001193125-16-640165 | Jul 1, 2016 | — |
| 6-K | FORM 6-K | 0001193125-16-622182 | Jun 15, 2016 | — |
| 6-K | FORM 6-K | 0001193125-16-600535 | May 24, 2016 | May 23, 2016 |
| 6-K | 6-K | 0001564590-16-018709 | May 10, 2016 | Mar 31, 2016 |
| 6-K | FORM 6-K | 0001193125-16-568916 | Apr 29, 2016 | Apr 28, 2016 |
| S-8 | FORM S-8 | 0001193125-16-556709 | Apr 26, 2016 | — |
| 6-K | FORM 6-K | 0001193125-16-550771 | Apr 22, 2016 | Apr 21, 2016 |
| SC 13G/A | MESOBLAST LIMITED | 0001193125-16-538712 | Apr 12, 2016 | — |
| SC 13G | MESOBLAST LIMITED | 0001193125-16-538702 | Apr 12, 2016 | — |
| 6-K | 6-K | 0001193125-16-528180 | Apr 4, 2016 | Apr 1, 2016 |
| 6-K | FORM 6-K | 0001193125-16-518094 | Mar 25, 2016 | — |
| 6-K | FORM 6-K | 0001193125-16-508741 | Mar 17, 2016 | — |
| 6-K | 6-K | 0001193125-16-482281 | Feb 26, 2016 | — |
| 6-K | FORM 6-K | 0001193125-16-465826 | Feb 17, 2016 | — |
| 6-K | 6-K | 0001193125-16-465695 | Feb 16, 2016 | — |
| SC 13G | SC 13G | 0001193125-16-464425 | Feb 16, 2016 | — |